FLECHTNER JESSICA BAKER (Chief Scientific Officer) sold 3.3% of their position (3.35K shares) of GENOCEA BIOSCIENCES, INC. on the open market
Open‑market sale worth $3.7K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 3/17/2022ACC: 0001457612-22-000032
Officer· Chief Scientific Officer
Since Nov 2018
+171.65K
Net shares
Net buyer
$3.7K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
175K acquired · 3.35K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+43.75K
Price / share
—
Trade value
—
% of position
76.7%
3/15/2022
57K→100.75K
Common Stock
Direct
Shares
−3.35K
Price / share
$1.10
Trade value
$3.68K
% of position
3.3%
3/16/2022
100.75K→97.41K
Total
Net shares
+40.40K
Net value
-$3.68K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/15/2022 | A · Award | +43.75K | — | — | 76.7% | 57K | 100.75K |
| Common Stock Direct | 3/16/2022 | S · Sale | −3.35K | $1.10 | $3.68K | 3.3% | 100.75K | 97.41K |
| Total | +40.40K | -$3.68K | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
131.25K shares
Shares
+131.25K
Strike price
1.11
Held after
131.25K
Exercisable
—
3/15/2022
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock131.25K shares | 3/15/2022 | A · Award | +131.25K | 1.11 | — | 131.25K |